---

---

symbols : TEVJF    exchanges : Nyse   

save search

---

HIV Drugs Market size is set to grow by USD 10.47 billion from 2023-2027, AbbVie Inc., Aspen Pharmacare Holdings Ltd and Aurobindo Pharma Ltd., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 23:00) - prnewswire.com
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| Email alert Add to watchlist
VTRS | News A | $11.36 0.98% 0.97% 4.7M |

Health Technology

| Email alert Add to watchlist
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| Email alert Add to watchlist
pharma abbvie set hiv key market

---

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| 2.8% | O: -0.04% H: 0.28% C: -0.16%
stelara fda biosimilar approval teva

---

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | News A | $11.36 0.98% 0.97% 4.7M |

Health Technology

| -0.62% | O: -0.53% H: 0.0% C: -1.24%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 0.61% | O: -1.46% H: 0.0% C: 0.0%
PHG | News | $21.01 1.94% 0.0% 2M |

Health Technology

| -0.29% | O: -1.21% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| 0.22% | O: -1.19% H: 0.52% C: -0.17%
VRNA | $15.6 -0.76% -0.77% 360K |

Health Technology

| -0.51% | O: 1.65% H: 2.43% C: 0.87%
reach treatment research market

---

Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
Published: 2024-04-16 (Crawled : 13:00) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M |

Health Technology

| -2.65% | O: 0.23% H: 0.23% C: -1.28%
austedo for meeting

---

Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
Published: 2024-04-11 (Crawled : 23:00) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M |

Health Technology

| -7.0% | O: -1.01% H: 2.04% C: 1.17%
ajovy for teva trial migraine china results

---

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -9.51% | O: -100.0% H: NaN% C: Infinity%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -0.62% | O: -1.67% H: 0.0% C: 0.0%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -8.98% | O: -0.29% H: 0.0% C: -1.97%
VTRS | News A | $11.36 0.98% 0.97% 4.7M |

Health Technology

| -4.01% | O: -0.6% H: 1.03% C: 0.52%
TMO | News | $574.59 4.78% -1.12% 2.5M |

Health Technology

| -6.93% | O: -2.01% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -0.94% | O: -1.16% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -2.64% | O: -0.32% H: 0.0% C: 0.0%
JAZZ | $109.685 0.79% 0.78% 380K |

Health Technology

| -5.88% | O: -1.71% H: 0.57% C: 0.37%
disorders system set market

---

Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
Published: 2024-04-09 (Crawled : 23:00) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M |

Health Technology

| -9.3% | O: -0.7% H: 0.07% C: -0.92%
first conference teva financial results

---

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 4.14% | O: -3.43% H: 6.21% C: 6.21%
VTRS | News A | $11.36 0.98% 0.97% 4.7M |

Health Technology

| -4.66% | O: -0.25% H: 1.1% C: -0.17%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.06% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -4.25% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.53 0.95% 0.0% 4M |

Health Technology

| -18.83% | O: 0.38% H: 0.0% C: -7.27%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -0.02% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -1.39% | O: 0.84% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 3.97% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

---

Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
Published: 2024-04-04 (Crawled : 00:00) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M |

Health Technology

| -8.78% | O: -0.42% H: 0.0% C: 0.0%
candidate biosimilar global for teva agreement

---

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| -4.25% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 2.99% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -0.6% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -1.16% | O: 0.52% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| -5.58% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -7.72% | O: 0.26% H: 2.03% C: 1.57%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -6.91% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $107.59 0.49% -0.09% 3.8M |

Health Technology

| -4.46% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -6.93% | O: -0.96% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 2.74% | O: -0.12% H: 0.25% C: -0.63%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -5.03% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

---

Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K |

n/a

| -12.48% | O: -1.58% H: 1.87% C: 0.53%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.15% | O: -0.03% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -5.79% | O: -0.89% H: 0.0% C: 0.0%
KMDA | $5.1 -0.99% 5.3K |

Health Technology

| -11.58% | O: 0.68% H: 0.0% C: -1.86%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -0.42% | O: 0.58% H: 1.2% C: 0.84%
business year update financial results

---

Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 4.01% | O: 2.01% H: 0.0% C: -2.01%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -6.58% | O: 1.12% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| -5.43% | O: 0.02% H: 0.79% C: 0.79%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| -0.41% | O: 0.9% H: 2.03% C: 1.89%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -6.5% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -4.26% | O: 0.01% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 3.64% | O: -0.19% H: 0.22% C: -0.21%
global set growth market

---

Global Fibrate Drugs Market Report 2024: A $5.14 Billion Market by 2034, Rising from S2.95 Billion in 2023
Published: 2024-03-11 (Crawled : 17:00) - prnewswire.com
ABT | News | $107.59 0.49% -0.09% 3.8M |

Health Technology

| -11.36% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -3.71% | O: 0.57% H: 0.0% C: 0.0%
report global market

---

Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published: 2024-02-28 (Crawled : 11:00) - prnewswire.com
ROIV | $10.935 3.16% 3.06% 5M |

Manufacturing

| -10.17% | O: -0.76% H: 0.51% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -8.12% | O: 0.05% H: 0.06% C: -0.95%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -6.81% | O: 0.67% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -6.09% | O: 0.6% H: 0.02% C: -1.03%
global set dermatological advanced growth market

---

Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-26 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 7.42% | O: 3.06% H: 0.0% C: -2.34%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| -4.97% | O: 0.23% H: 1.16% C: 0.08%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -4.88% | O: -0.19% H: 0.23% C: -2.02%
UTHR | $234.445 0.16% 0.16% 420K |

Health Technology

| 3.1% | O: -0.48% H: 1.17% C: -1.04%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 6.53% | O: 0.38% H: 0.44% C: -0.23%
reach research market

---

United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published: 2024-02-22 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -7.54% | O: 0.37% H: 0.58% C: 0.58%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -7.81% | O: 0.89% H: 0.4% C: 0.17%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| -4.98% | O: 0.57% H: 0.47% C: -0.58%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -4.27% | O: 0.14% H: 1.01% C: 0.51%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -5.01% | O: 0.29% H: 0.93% C: 0.47%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -3.42% | O: 0.97% H: 0.0% C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M |

Health Technology

| -8.01% | O: 0.65% H: 1.35% C: 0.41%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -4.65% | O: 0.47% H: 2.0% C: 0.93%
pharmaceuticals market

---

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| -5.41% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 9.24% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -6.69% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $64.93 -4.38% 6.2K |

Manufacturing

| 27.56% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -14.3% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -9.36% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -7.6% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| -3.22% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| -1.95% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -3.48% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -4.79% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -1.81% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 7.74% | O: -2.81% H: 2.08% C: 1.38%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| -4.07% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

---

PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
Published: 2024-02-21 (Crawled : 09:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 7.96% | O: -0.88% H: 1.75% C: -0.29%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.9% | O: 0.8% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -5.02% | O: -0.25% H: 0.0% C: 0.0%
KPTI | $1.085 -3.98% -4.15% 1.6M |

Health Technology

| -6.61% | O: -1.65% H: 3.36% C: 1.68%
CKPT | $1.43 -1.38% -1.4% 350K |

Health Technology

| -26.77% | O: 0.0% H: 1.26% C: -3.03%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 7.83% | O: -1.01% H: 1.1% C: 1.1%
report year reach market

---

Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.38% | O: 2.72% H: 0.0% C: -0.8%
TEVA | $13.01 1.01% 0.0% 8.9M |

Health Technology

| -1.08% | O: 1.31% H: 0.67% C: -0.91%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| 0.1% | O: 2.53% H: 0.0% C: 0.0%
antibody meeting teva

---

Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published: 2024-02-15 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.488 -17.59% 1.7K |

Health Technology

| -55.26% | O: 0.79% H: 0.0% C: -3.21%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.42% | O: 1.66% H: 0.0% C: -1.59%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| -4.41% | O: 1.66% H: 0.0% C: -1.04%
TRUMY | $16.94 0.79% 52K |

Manufacturing

| -54.46% | O: 0.27% H: 0.0% C: -2.6%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| -4.88% | O: 0.37% H: 0.57% C: 0.19%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -5.57% | O: -0.83% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| -4.93% | O: 0.01% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -0.51% | O: -0.6% H: 0.0% C: 0.0%
drug patent report review global advanced market

---

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News M | $4.6 164.37% 62.17% 28M |

AGBA | $2.94 135.2% 57.48% 66M |

Finance

EDBL | News | $6.46 71.81% 41.8% 2M |

MTC | $2.25 44.23% 30.67% 6M |

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M |

Finance

SHIM | $3.05 35.56% 26.23% 1.1M |

HKIT | $1.345 31.86% 24.16% 390K |

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M |

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K |

POET | $1.59 27.2% 21.38% 4.2M |

Manufacturing

---

Your saved searches

---